Computational refinement of functional single nucleotide polymorphisms associated with ATM gene

C George Priya Doss1, B Rajith

  • 1Centre for Nanobiotechnology, Medical Biotechnology Division, School of Biosciences and Technology, Vellore Institute of Technology University, Vellore, Tamil Nadu, India. georgepriyadoss@vit.ac.in

Plos One
|April 25, 2012
PubMed
Abstract

Insights

Investigating single nucleotide polymorphisms (SNPs) in the ATM gene reveals their impact on cancer susceptibility. Computational analysis characterized functional variants, aiding understanding of genetic differences in disease risk.

Area of Science:

  • Genomics
  • Molecular Biology
  • Cancer Research

Background:

  • Understanding the molecular basis of disease is crucial in modern biology and medicine.
  • Single nucleotide polymorphisms (SNPs) can alter protein function and influence disease development.
  • The ATM gene is frequently altered by single amino acid substitutions, contributing to various cancers, but their regulatory effects remain unclear.

Purpose of the Study:

  • To systematically analyze and characterize deleterious non-synonymous SNPs (nsSNPs) in the ATM gene.
  • To investigate how these nsSNPs affect gene regulation, protein function, and cancer susceptibility.
  • To explore the potential influence of nsSNPs on protein Post-Translational Modifications (PTMs) in the ATM gene.

Main Methods:

  • Utilized various computational methods for analyzing deleterious nsSNPs in the ATM gene.
  • Developed an integrative scoring system combined with amino acid residue sequence conservation for nsSNP analysis.
  • Extended the analysis to include SNPs potentially affecting ATM gene's protein Post-Translational Modifications.

Main Results:

  • Identified and characterized functional nsSNPs within both coding and non-coding regions of the ATM gene.
  • Demonstrated that specific nsSNPs can alter the expression and function of the ATM gene.
  • Provided insights into how nsSNPs may influence protein Post-Translational Modifications.

Conclusions:

  • The in silico characterization of nsSNPs affecting ATM gene function is essential for understanding their role in disease.
  • This systematic analysis provides a foundation for comprehending genetic variations that influence cancer susceptibility.
  • The findings contribute to a better understanding of the molecular underpinnings of ATM-related disorders.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...